Gregg Peterson

Life sciences R&D executive with 25 years of experience owning end-to-end global clinical programs, teams, and operating infrastructure across biologics, pharmaceuticals and injectable ROAs. Proven track record leading Phase I first-in-human through Phase IV oncology programs, including building and leading internal clinical teams, protocol and operational strategy, CRO selection and management, budgets and forecasts, risk management and regulatory submissions. Extensive experience orchestrating trials across North America, Europe, and Asia-Pacific, leading to multiple FDA and EMA approvals. Recognized for building high-performing teams and solving complex execution challenges to deliver high-quality clinical programs.